Company Filing History:
4 out of 822 
1 out of 167 
Years Active: 2016-2022
Title: Innovations by Inventor Peter Hoelig
Introduction
Peter Hoelig, an accomplished inventor based in Waechtersbach, Germany, has made significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, Hoelig focuses on the development of innovative solid dosage forms, particularly in the area of drug delivery systems that can enhance treatment efficacy for various diseases, including cancer.
Latest Patents
Hoelig's latest patents reflect his dedication to advancing medical treatments through innovative approaches. One of his notable inventions is a melt-extruded solid dispersion containing an apoptosis-inducing agent. This pro-apoptotic solid dispersion is designed to include a Bcl-2 family protein inhibitory compound, which is presented in an essentially non-crystalline form. The solid matrix incorporates a pharmaceutically acceptable water-soluble polymeric carrier and a surfactant, making it suitable for oral administration. This innovation targets diseases characterized by the overexpression of anti-apoptotic Bcl-2 family proteins, offering hope for patients suffering from cancer or immune and autoimmune diseases.
Additionally, he has developed solid antiviral dosage forms that comprise antiviral compounds and methods for their use in treating antiviral infections. This patent showcases his commitment to providing effective solutions for pressing health challenges.
Career Highlights
Throughout his career, Peter Hoelig has been affiliated with notable companies, including AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. His experience in such reputable organizations underscores his expertise in pharmaceutical innovation.
Collaborations
Hoelig has collaborated with esteemed professionals in the field, including Jonathan Mark Miller and John B. Morris. Working alongside these individuals has undoubtedly enhanced his research and development capabilities, leading to groundbreaking advancements in drug formulations.
Conclusion
Peter Hoelig stands out as a prominent inventor whose innovative patents are paving the way for improved treatment options in the pharmaceutical industry. His work continues to inspire advancements that may one day change the landscape of medical therapies. The intersection of his expertise, collaborative efforts, and commitment to innovation lays a strong foundation for future contributions to healthcare and patient outcomes.